MREO
Mereo Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MREO fundamentals
Mereo Biopharma (MREO) released its earnings on Nov 10, 2025: revenue was 300.00K (YoY 0.00%), missed estimates; EPS was -0.01 (YoY +50.00%), missed estimates.
Revenue / YoY
300.00K
0.00%
EPS / YoY
-0.01
+50.00%
Report date
Nov 10, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Mereo Biopharma (MREO) key financial stats and ratios, covering profitability, financial health, and leverage.
Mereo Biopharma (MREO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Mereo Biopharma (MREO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Mereo Biopharma (MREO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Mereo Biopharma (MREO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Mereo Biopharma (MREO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Mereo Biopharma's earnings call?What is Mereo Biopharma's latest dividend and current dividend yield?What were the key takeaways from Mereo Biopharma’s earnings call?What guidance did Mereo Biopharma's management provide for the next earnings period?What does Mereo Biopharma do and what are its main business segments?Did Mereo Biopharma beat or miss consensus estimates last quarter?What factors drove the changes in Mereo Biopharma's revenue and profit?What is the market's earnings forecast for Mereo Biopharma next quarter?
